LogicBio Therapeutics, Inc. Notes Payable
LogicBio Therapeutics, Inc. had Notes Payable of $5.56 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:NotesPayable · last filed 2022-11-14
- 2022-09-30: Notes Payable $5.56M.
- 2022-06-30: Notes Payable $6.39M.
- 2022-03-31: Notes Payable $7.22M.
- 2021-12-31: Notes Payable $8.05M.
| Period end | Notes Payable |
|---|---|
| 2022-09-30 | $5.56M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.39M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $7.22M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $8.05M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $8.89M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $9.72M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $10.00M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $10.00M 10-K · filed 2022-03-04 |
| 2020-09-30 | $10.00M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $10.00M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $10.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $10.00M 10-K · filed 2021-03-15 |
| 2019-09-30 | $10.00M 10-Q · filed 2019-11-12 |